Tag : cancer biomarkers

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announced that it appointed Jeffrey Elliott to its Board...

The feature draws on expert-written articles and more than 10 years of data and insights InsideTracker, the leading personalized health platform, today announced the addition...

Investment will allow NeuroTherapia to continue the development of an orally available treatment for Alzheimer’s disease. NeuroTherapia, Inc., a clinical-stage company and Cleveland Clinic Innovations portfolio...

Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis and Research Agreement Plans to Facilitate a Technology...

uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of...

Datavant, the leading health data platform company, today announced it has signed a multi-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS), to power...

Enhances mission to advance the care of patients facing the potential diagnosis of a neurodegenerative disease CND Life Sciences (CND), a medical technology company pioneering the...

Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions Proscia®, a global leader in AI-enabled pathology solutions for...

Vikas Ahuja brings over 20 years of strategic business experience in the life sciences industry from Quest Diagnostics, Ambry Genetics and Mallinckrodt Pharmaceuticals Nucleai, a...